FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Glenmark Pharmaceuticals Mometasone Furoate Recall

Mometasone Furoate, Topical Solution USP, 0

Glenmark Pharmaceuticals Inc., USA · Mahwah, NJ

Risk level
Class III
Reported by FDA
Jul 13, 2022
Recall ID
D-1173-2022
Check your lot numberHow we source this data

Summary

Glenmark Pharmaceuticals recalled Mometasone Furoate starting Jun 16, 2022. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1173-2022 on Jul 13, 2022. Reason: Defective Container. Status: Terminated.

Why it was recalled

Defective Container

Product description

Mometasone Furoate, Topical Solution USP, 0.1 % Lotion, a) 30 ml-bottle (NDC 68462-385-37), b) 60 ml-bottle (NDC 68462-385-02), Rx only, Manufactured by: Glenmark Pharmaceuticals Limited, Baddi Himachal Pradesh 173205, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah NJ 07430.

Lot numbers, UPCs & expiration codes

Lot # a) 05201358, Exp 06/2022; 05210287, 05210288, Exp 01/2023; 05211446, Exp 07/2023; 05211704, 05211714, Exp 08/2023; 05212217, Exp 10/2023: b) 05201358, Exp 06/2022; 05210287, 05210288, 05210424, Exp 01/2023; 05210425, 05210435, Exp 02/2023; 05211427, 05211439, 05211445, Exp 07/2023; 05211723, 05211731, 05211850, 05211864, Exp 08/2023; 05212226, 05212250, 05212261, Exp 10/2023.

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1173-2022
Classification
Class III
Status
Terminated
Recall initiated
Jun 16, 2022
FDA report date
Jul 13, 2022
Quantity
98, 307 packs
Recall type
Voluntary: Firm initiated
Recalling firm
Glenmark Pharmaceuticals Inc., USA

Original FDA data

Every field from FDA enforcement report D-1173-2022, exactly as published.

Show all FDA fields
City
Mahwah
State
NJ
Status
Terminated
Country
United States
Event ID
90473
Address
750 Corporate Dr
Code information
Lot # a) 05201358, Exp 06/2022; 05210287, 05210288, Exp 01/2023; 05211446, Exp 07/2023; 05211704, 05211714, Exp 08/2023; 05212217, Exp 10/2023: b) 05201358, Exp 06/2022; 05210287, 05210288, 05210424, Exp 01/2023; 05210425, 05210435, Exp 02/2023; 05211427, 05211439, 05211445, Exp 07/2023; 05211723, 05211731, 05211850, 05211864, Exp 08/2023; 05212226, 05212250, 05212261, Exp 10/2023.
Postal code
07430-2009
Report date
Jul 13, 2022
Product type
Drugs
Recall number
D-1173-2022
Classification
Class III
Recalling firm
Glenmark Pharmaceuticals Inc., USA
Product quantity
98, 307 packs
Termination date
Feb 24, 2026
Reason for recall
Defective Container
Voluntary / mandated
Voluntary: Firm initiated
Product description
Mometasone Furoate, Topical Solution USP, 0.1 % Lotion, a) 30 ml-bottle (NDC 68462-385-37), b) 60 ml-bottle (NDC 68462-385-02), Rx only, Manufactured by: Glenmark Pharmaceuticals Limited, Baddi Himachal Pradesh 173205, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah NJ 07430.
Distribution pattern
Nationwide in the USA
Recall initiation date
Jun 16, 2022
Initial firm notification
Letter
Center classification date
Jul 1, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1173-2022, published Jul 13, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls